Joe DePinto, McKesson’s head of cell and gene advanced therapies, supports patients, providers and payers throughout the treatment journey. He’s particularly passionate about helping patients get access to groundbreaking therapeutic interventions. Maria Whitman gets his perspective on the current state of cell and gene therapy and the promising advancements that can ensure more patients receive these treatments.
Highlights include:
- Why strategic partnerships and digital information are critical
- How McKesson is working to improve patient access and support
- The need for standardization and data transparency
Add insights to your inbox
We’ll send you content you’ll want to read – and put to use.
